Skip Navigation

European Journal of Heart Failure 1999 1(1):59-65; doi:10.1016/S1388-9842(98)00010-5
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yu, C. M.
Right arrow Articles by Sanderson, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, C. M.
Right arrow Articles by Sanderson, J. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1999 European Society of Cardiology

Plasma brain natriuretic peptide — an independent predictor of cardiovascular mortality in acute heart failure

Cheuk M. Yu and John E. Sanderson*

Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital 9/F Clinical Sciences Bldg, Shatin, N. T., Hong Kong, People's Republic of China

* Corresponding author. Tel.: +852 26322064; fax: +852 26373852; e-mail: jesanderson{at}cuhk.edu.hk


  Abstract

Purpose: To examine the prognostic importance of both plasma atrial natriuretic and B-(brain natriuretic peptide) following an episode of acute heart failure.

Subjects and methods: A prospective cohort of 91 patients admitted into hospital with acute heart failure were recruited. After initial in-hospital management plasma ANP and BNP levels were measured by radioimmunoassay, and echocardiography was performed on the same day. Patients were followed up for 12 months and the main outcome measure was cardiovascular death.

Results: Plasma ANP and BNP levels were significantly higher in patients who died of a cardiovascular cause within 12 months (P < 0.001 and P < 0.0001, respectively) or at 1-month (P < 0.05 and P < 0.001) after recruitment. By Kaplan-Meier estimated life-table curves, patients with above median plasma ANP or BNP levels had significantly higher 1-year mortality (42.5% vs. 11.6%, both P < 0.005). By multivariate Cox proportional hazard regression analysis, the plasma BNP level was the most important prognostic factor predicting mortality ({chi}2 = 18.3, P < 0.0001), followed by age ({chi}2 = 11.5, P < 0.001). Other factors including ANP, left ventricular ejection fraction by M-mode echocardiography, pulmonary arterial pressure, sex, cause of heart failure as well as New York Heart Association class were not significant.

Conclusion: A plasma BNP level has independent and at least short-term prognostic significance in patients admitted with acute heart failure. This non-invasive and readily available blood test should be considered for risk stratification in patients with acute heart failure.

Key Words: Heart failure • Prognosis • Atrial natriuretic factor • Brain natriuretic factor


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur J Heart FailHome page
K. H. Miettinen, J. Lassus, V.-P. Harjola, K. Siirila-Waris, J. Melin, K. R. Punnonen, M. S. Nieminen, M. Laakso, and K. J. Peuhkurinen
Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure
Eur J Heart Fail, April 1, 2008; 10(4): 396 - 403.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. Y.-M. Wang, C. W.-K. Lam, C.-M. Yu, M. Wang, I. H.-S. Chan, Y. Zhang, S.-F. Lui, and J. E. Sanderson
N-Terminal Pro-Brain Natriuretic Peptide: An Independent Risk Predictor of Cardiovascular Congestion, Mortality, and Adverse Cardiovascular Outcomes in Chronic Peritoneal Dialysis Patients
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 321 - 330.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
A Verma, F Kilicaslan, D O Martin, S Minor, R Starling, N F Marrouche, S Almahammed, O M Wazni, S Duggal, R Zuzek, et al.
Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies
Heart, February 1, 2006; 92(2): 190 - 195.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. Luchner, C. Hengstenberg, H. Lowel, G. A.J. Riegger, H. Schunkert, and S. Holmer
Effect of Compensated Renal Dysfunction on Approved Heart Failure Markers: Direct Comparison of Brain Natriuretic Peptide (BNP) and N-Terminal Pro-BNP
Hypertension, July 1, 2005; 46(1): 118 - 123.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
V. Verdiani, C. Nozzoli, F. Bacci, A. Cecchin, M. S. Rutili, S. Paladini, and I. Olivotto
Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit
Eur J Heart Fail, June 1, 2005; 7(4): 566 - 571.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
J. A Doust, E. Pietrzak, A. Dobson, and P. Glasziou
How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review
BMJ, March 19, 2005; 330(7492): 625.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
J. E. Sanderson
BNP or echocardiography for monitoring heart failure?
Eur. Heart J., October 2, 2004; 25(20): 1763 - 1764.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
A. Gackowski, R. Isnard, J.-L. Golmard, F. Pousset, A. Carayon, G. Montalescot, J.-S. Hulot, D. Thomas, W. Piwowarska, and M. Komajda
Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure
Eur. Heart J., October 2, 2004; 25(20): 1788 - 1796.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
J. G.F. Cleland and K. Goode
Natriuretic peptides for heart failure. Fashionable? Useful? Necessary?
Eur J Heart Fail, March 15, 2004; 6(3): 253 - 255.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
M.R Cowie, P Jourdain, A Maisel, U Dahlstrom, F Follath, R Isnard, A Luchner, T McDonagh, J Mair, M Nieminen, et al.
Clinical applications of B-type natriuretic peptide (BNP) testing
Eur. Heart J., October 1, 2003; 24(19): 1710 - 1718.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
R. J. O'Brien, I. B. Squire, B. Demme, J. E. Davies, and L. L. Ng
Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF
Eur J Heart Fail, August 1, 2003; 5(4): 499 - 506.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
C.A. Kelly, D.E. Newby, T.A. Mcdonagh, T.W. Mackay, J. Barr, N.A. Boon, H.J. Dargie, and N.J. Douglas
Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. Effects on plasma brain natriuretic peptide concentrations
Eur. Heart J., September 1, 2002; 23(17): 1379 - 1386.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
T. Kihara, S. Biro, M. Imamura, S. Yoshifuku, K. Takasaki, Y. Ikeda, Y. Otuji, S. Minagoe, Y. Toyama, and C. Tei
Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure
J. Am. Coll. Cardiol., March 6, 2002; 39(5): 754 - 759.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
G. A Sagnella
Practical implications of current natriuretic peptide research
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 304 - 315.
[PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.